|
|
|
| Application effect of comprehensive management in chronic kidney disease patients in stage 3-4 |
| ZHANG Heping1 XU Dan1 YUE Yanlin1 ZHANG Jie1 LIU Jiali1 WANG Xiaohong2 ZHAO Zongyang3 LIAO Huawei1▲ |
1.Department of Nephrology, Affiliated Hospital of North Sichuan Medical College, Sichuan Province, Nanchong 637000, China;
2.Department of Internal Medicine, Kangqiao Hospital of Xichong County, Sichuan Province, Nanchong 637000, China;
3.Department of Internal Medicine, Nanchong Youhao Hospital, Sichuan Province, Nanchong 637000, China |
|
|
|
Abstract Objective To investigate the application effect of comprehensive management in patients with stage 3-4 chronic kidney disease. Methods Eighty-one patients with chronic kidney disease in stage 3-4 were selected from Affiliated Hospitals of North Sichuan Medical College, Kangqiao Hospital of Xichong Country and Nanchong Youhao Hospital from March 2016 to February 2018. The patients were randomly divided into the control group (40 cases) and the observation group (41 cases) by lottery, and they were treated with routine management and comprehensive management respectively. The differences in management effects between the two groups were observed for 3 months. Results The scores of diet management, treatment management, somatic activity management and psychosocial management in the observation group were higher than those in the control group, and the differences were statistically significant (P ＜ 0.05). After 3 months of management, the proportion of nutritional normal patients in the observation group were significantly higher than those in the control group, while the level of serum uric acid was lower than that in the control group, and the differences were statistically significant (P ＜ 0.05). Conclusion The application of comprehensive management in patients with chronic kidney disease in stage 3-4 is very effective. It can significantly improve the nutritional status of patients and reduce the level of serum uric acid, while enhance the ability of disease management. It is worthy to promote.
|
|
|
|
|
|
[1] Washinger K. An integrated approach：hypertension management in patients with chronic kidney disease [J]. Advance for Nps & Pas，2014，5（1）：16-17.
[2] Vakilzadeh N，Phan O，Ogna V F，et al. New aspects of hypertension management in patients with chronic kidney disease [J]. Revue Médicale Suisse，2014，10（441）：1668-1672.
[3] 林建荣，高艳，王玲，等.系统营养管理干预对慢性肾脏病患者临床转归的影响[J].湖北理工学院学报，2018，12（1）：17-18.
[4] 上海慢性肾脏病早发现及规范化诊治与示范项目专家组，高翔，梅长林.慢性肾脏病筛查诊断及防治指南[J].中国实用内科杂志，2017，37（1）：28-34.
[5] 赖玮婧，刘芳，付平.慢性肾脏病评估及管理临床实践指南解读——从K/DOQI到KDIGO[J].中国实用内科杂志，2013，33（6）：448-453.
[6] 杨楠，蔡亚宏，刘倩，等.营养指导与饮食控制对慢性肾脏病患者自我管理和营养状况的影响[J].临床医学工程，2018，10（1）：105-106.
[7] 乔德丽，山岚，冯景，等.126例维持性血液透析患者膳食调查[J].中国食物与营养，2017，23（10）：81-85
[8] 傅贤芳，陈文宇.药物干预与认知干预在慢性阻塞性肺疾病（COPD）患者中的应用[J].中国生化药物杂志，2017， 10（4）：435-437.
[9] 邹宏明.性格心理学[M].厦门：鹭江出版社，2015.
[10] 孔令娜.慢性乙型肝炎抗病毒治疗患者自我管理量表的编制及初步应用研究[D].重庆：重庆医科大学，2015.
[11] 王亚华，王亚平.高尿酸血症肾损害的研究进展[J].中国循证心血管医学杂志，2013，5（1）：91-92.
[12] Chen SD，Zhao RS，Pharmacy DO，et al. Medication therapy management for outpatients with chronic kidney disease [J]. Chin J New Drug，2016，25（14）：1667-1672.
[13] 李小庭，童俊容，张虹，等.维持性血液透析患者血清尿酸水平与死亡风险的关系分析[J].新医学，2014，45（8）：505-508.
[14] 屈建良，唐晓红.不同分期慢性肾脏疾病患者炎性因子、血脂等指标比较[J].医学综述，2016，22（9）：1860-1863.
[15] 吴文慧.维持性血液透析患者代谢性酸中毒的研究进展[J].医学综述，2014，20（21）：3913-3915.
[16] 段楠，刘怡，李海霞，等.糖化白蛋白诱导人近端肾小管上皮细胞产生损伤与炎性反应的表达[J].首都医科大学学报，2017，38（2）：289-294.
[17] 韩菲，杨立成，孙红喜，等.2型糖尿病合并不同程度慢性肾脏病患者动态血压节律变化[J].中国糖尿病杂志，2015，7（11）：664-664.
[18] 余伟清.冠心病合并高尿酸血症患者中医体质与冠脉病变的相关性[D].广州：广州中医药大学，2016.
[19] 赵金娇，马利丹，周慧，等.肥胖痛风患者的临床特点分析[J].中国医学创新，2017，14（5）：1-5.
[20] 张菲菲，李华，孙永胜，等.血尿酸水平与高血压伴急性脑卒中临床相关性研究[J].中国现代医生，2018，56（12）：31-34.
[21] 蓝活，梁立燕，汪涛，等.老年高血压患者血清尿酸水平与颈动脉粥样硬化的相关性[J].海南医学，2016，27（5）：14-16.
[22] 陈蕊，毕光宇.加强综合管理对慢性肾脏病患者血压控制的影响[J].中国保健营养，2016，26（24）：301-302. |
|
|
|
